Document is current
Any future updates will be listed below
-
Authors
Kong, Lingjia
Subramanian, Sathish
Segerstolpe, Åsa
Tran, Vy
Shih, Angela R. https://orcid.org/0000-0002-8945-5997
Carter, Grace T. https://orcid.org/0000-0001-5514-4237
Kunitake, Hiroko
Twardus, Shaina W.
Li, Jasmine
Gandhi, Shivam
Kaper, Marco E.
Cauley, Christy
Chen, Eric J.
Porter, Caroline B. M.
Delorey, Toni M. https://orcid.org/0000-0001-6614-3803
Bordeianou, Liliana
Ricciardi, Rocco
Ananthakrishnan, Ashwin N.
Lau, Helena
Graham, Daniel B. https://orcid.org/0000-0002-8403-8115
Hodin, Richard
Deguine, Jacques https://orcid.org/0000-0001-9218-3040
Smillie, Christopher S. https://orcid.org/0000-0002-7606-3433
Xavier, Ramnik J. https://orcid.org/0000-0002-5630-5167
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (P30 DK043351, RC2 DK135492, P30 DK043351)
- License Information
-
More Information
Article History
Received: 9 August 2024
Accepted: 1 May 2025
First Online: 25 June 2025
Competing interests
: R.J.X. is cofounder of Jnana Therapeutics, Scientific Advisory Board member at Nestlé, Magnet BioMedicine and Arena BioWorks, and Board Director at MoonLake Immunotherapeutics; these organizations had no roles in this study. S.S. is currently an employee of Vertex Pharmaceuticals, which also had no role in this study. The other authors declare no competing interests.
